Skip to content

Randomized Clinical Trial of Angiosculpt Balloon Angioplasty versus Conventional Balloon Angioplasty in Hemodialysis Arteriovenous Fistula Stenoses

Randomized Clinical Trial of Angiosculpt Balloon Angioplasty versus Conventional Balloon Angioplasty in Hemodialysis Arteriovenous Fistula Stenoses

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010350
Enrollment
Unknown
Registered
2017-01-06
Start date
2017-01-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis Arteriovenous Fistula Stenoses

Interventions

1:Balloon angioplasty with conventional balloon catheter
2:Balloon angioplasty with AngioSculpt PTA balloon catheter

Sponsors

Princess Margaret Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Percutaneous Transluminal Angioplasty will performed in end-stage renal failure patients with hemodynamically significant (defined as >50%) stenosis of the autogenous fistula.

Exclusion criteria

Exclusion criteria: - Patient refusing treatment - The reference segment diameter is not suitable for available catheter design - Previous PTA for the same lesion - Associated significant (>50%) central venous stenosis - Multiple significant (>50%) stenosis - The patient is minor (<18 years old) - Previous access thrombectomy - Positive pregnancy test result within 7 days before enrolment - Patient is scheduled for a kidney transplant - Life expectancy <6 months - The patient has a known allergy to heparin, aspirin or other anticoagulant/ antiplatelet therapies - The patient is currently enrolled in another investigational device or drug trial - The patient is currently breast-feeding, pregnant or intends to become pregnant

Design outcomes

Primary

MeasureTime frame
Patency of the target lesion of control and experimental groups;

Secondary

MeasureTime frame
Immediate angiographic scoring success, defined as residual diameter stenosis smaller than 30% and absence of flow-limiting dissection on visual assessment after scoring balloon treatment;Hemodialysis success, defined as restoration of normal blood flow through the treated vascular lesion;Peri-procedural complications (less than 24 hours) will be evaluated including death, stroke, myocardial infarction of the scoring balloon treated lesion, significant distal embolization in the target limb and thrombosis of target limb.;Complications at 30 days including death, stroke, myocardial infarction, emergent percutaneous or surgical revascularization of the scoring balloon treated lesion, significant distal embolization in the target limb and thrombosis of target limb.;

Countries

China

Contacts

Public ContactWing-hang Luk

Diagnostic Radiology Department, Princess Margaret Hospital

lukwinghang@gmail.com+852 29902717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026